vimarsana.com

Latest Breaking News On - Halberd corp - Page 1 : vimarsana.com

Penny Stocks, Shifts in Trends, Notable Performances, and Strategic Developments, Opportunities: CLNV, HALB, SPZI, HNRC, ENZC -January 10, 2024 at 04:31 am EST

Transmucosal Drug Delivery Pipeline Research Report 2023: Formulate Effective R&D Strategies with Key Insights

Analyzing Halberd (HALB) & The Competition

Halberd (OTCMKTS:HALB – Get Rating) is one of 343 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Halberd to similar companies based on the strength of its valuation, earnings, profitability, risk, analyst recommendations, institutional ownership and dividends. Insider & Institutional Ownership 22.3% of shares […]

Halberd (HALB) versus Its Rivals Critical Review

Halberd (OTCMKTS:HALB – Get Rating) is one of 361 public companies in the “Biotechnology” industry, but how does it contrast to its peers? We will compare Halberd to related companies based on the strength of its analyst recommendations, profitability, earnings, dividends, institutional ownership, valuation and risk. Institutional and Insider Ownership 26.0% of shares of all […]

Halberd Co (OTCMKTS:HALB) Short Interest Up 14 0% in April

Halberd Co. (OTCMKTS:HALB – Get Rating) was the recipient of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 88,700 shares, an increase of 14.0% from the March 31st total of 77,800 shares. Based on an average daily volume of 3,158,700 shares, the days-to-cover […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.